Home > News Expertise > Page 4
What is a biosimilar product? A biosimilar is a biological medicine (i.e., a medicine whose active substance is made by
DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2023 categories : In addition to these collective
Launched in June 2021 by three founding members (AstraZeneca, Docaposte and Impact Healthcare), the AgorIA Santé consortium aims at bringing
DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2022 categories: In addition to these collective rankings,
Gaëlle Merlier is joining the DELSOL Avocats Life Sciences practice as a partner accompanied by associate Bastien Pavec, who worked
AstraZeneca, Docaposte and Impact Healthcare have created the «Agoria Santé» consortium to provide public and private players with a controlled
DELSOL Avocats is proud to be ranked in 6 Legal 500 EMEA 2021 categories : The Regions – Tier 1
DELSOL Avocats is proud to be ranked in 8 categories by the Legal 500 Paris 2020 : -*Construction – Tier
Considering the latest developments relating to Covid-19 and government announcements, we would like to inform you with full transparency of